نتایج جستجو برای: fgfr3

تعداد نتایج: 1106  

2018
Mélanie Mahe Florent Dufour Hélène Neyret-Kahn Aura Moreno-Vega Claire Beraud Mingjun Shi Imene Hamaidi Virginia Sanchez-Quiles Clementine Krucker Marion Dorland-Galliot Elodie Chapeaublanc Remy Nicolle Hervé Lang Celio Pouponnot Thierry Massfelder François Radvanyi Isabelle Bernard-Pierrot

FGFR3 alterations (mutations or translocation) are among the most frequent genetic events in bladder carcinoma. They lead to an aberrant activation of FGFR3 signaling, conferring an oncogenic dependence, which we studied here. We discovered a positive feedback loop, in which the activation of p38 and AKT downstream from the altered FGFR3 upregulates MYC mRNA levels and stabilizes MYC protein, r...

Journal: :Human molecular genetics 2009
Lisa Salazar Tamara Kashiwada Pavel Krejci Paul Muchowski Daniel Donoghue William R Wilcox Leslie Michels Thompson

Ectopic activation of fibroblast growth factor receptor 3 (FGFR3) is associated with several cancers, including multiple myeloma (MM). FGFR3 inhibition in these cells inhibits proliferation and induces apoptosis, validating FGFR3 signaling as a therapeutic target in t(4;14) MM cases. We have identified the PI3K regulatory subunit, p85alpha, as a novel interactor of FGFR3 by yeast two-hybrid, an...

2015
Pamela S. Ellis Sarah Burbridge Sandrine Soubes Kyoji Ohyama Nadav Ben-Haim Canhe Chen Kim Dale Michael M. Shen Daniel Constam Marysia Placzek

The secreted glycoprotein sonic hedgehog (Shh) is expressed in the prechordal mesoderm, where it plays a crucial role in induction and patterning of the ventral forebrain. Currently little is known about how Shh is regulated in prechordal tissue. Here we show that in the embryonic chick, Shh is expressed transiently in prechordal mesoderm, and is governed by unprocessed Nodal. Exposure of prech...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
J Javier Gómez-Román Pilar Saenz Miguel Molina Jorge Cuevas González Kepa Escuredo Simon Santa Cruz Corina Junquera Laureano Simón Antonio Martínez J Luis Gutiérrez Baños Marta López-Brea Clara Esparza J Fernando Val-Bernal

PURPOSE Fibroblast growth factor receptor 3 (FGFR3) mutations have been associated with achondroplastic syndromes and urinary bladder carcinomas. Here we describe changes in FGFR3 mRNA and protein expression in transitional carcinomas and determine the effect of monoclonal antibodies against FGFR3 in RT-112 cell line proliferation. EXPERIMENTAL DESIGN We used microarray tools to evaluate FGFR...

سابقه و هدف: ژن FGFR3 نقش مهمی در تنظیم رشد، تمایز و رگ زایی دارد. تغییرات ژنتیکی ژن FGFR3 یکی از عوامل موثر در ابتلا به سرطان مثانه می باشد. جهش های فعال FGFR3 در حدود 70% از تومورهای مثانه غیرمهاجم به عضله مشاهده شده است. هدف از این مطالعه بررسی ارتباط جهشT375C  ژن FGFR3 درDNA   ژنومی استخراجی از اپی تلیال ادرار و خطر سرطان مثانه می باشد. مواد و روش­ها: در این مطالعه مورد-شاهدی، تعداد 100 فرد...

Journal: :The Journal of clinical investigation 2009
Jing Qing Xiangnan Du Yongmei Chen Pamela Chan Hao Li Ping Wu Scot Marsters Scott Stawicki Janet Tien Klara Totpal Sarajane Ross Susanna Stinson David Dornan Dorothy French Qian-Rena Wang Jean-Philippe Stephan Yan Wu Christian Wiesmann Avi Ashkenazi

Overexpression of FGF receptor 3 (FGFR3) is implicated in the development of t(4;14)-positive multiple myeloma. While FGFR3 is frequently overexpressed and/or activated through mutations in bladder cancer, the functional importance of FGFR3 and its potential as a specific therapeutic target in this disease have not been elucidated in vivo. Here we report that inducible knockdown of FGFR3 in hum...

2012
Stephen R Lyle Chung-Cheng Hsieh Cecilia A Fernandez Anthony P Shuber

BACKGROUND Mutations in FGFR3 have been shown to occur in tumors of the upper urothelial tract and may be indicative of a good prognosis. In bladder tumors, the combination of FGFR3 mutation status and Ki-67 level has been used to define a tumor's molecular grade and predict survival. Pathological evaluation of upper urothelial tumors is currently the best predictor of prognosis, but suffers fr...

Journal: :Human molecular genetics 2012
Aurélie Jonquoy Emilie Mugniery Catherine Benoist-Lasselin Nabil Kaci Laurent Le Corre Florent Barbault Anne-Lise Girard Yves Le Merrer Patricia Busca Laurent Schibler Arnold Munnich Laurence Legeai-Mallet

Activating germline fibroblast growth factor receptor 3 (FGFR3) mutations cause achondroplasia (ACH), the most common form of human dwarfism and a spectrum of skeletal dysplasias. FGFR3 is a tyrosine kinase receptor and constitutive FGFR3 activation impairs endochondral ossification and triggers severe disorganization of the cartilage with shortening of long bones. To decipher the role of FGFR3...

2010
Nan Su Xiaoling Xu Cuiling Li Qifen He Ling Zhao Can Li Siyu Chen Fengtao Luo Lingxian Yi Xiaolan Du Haiyang Huang Chuxia Deng Lin Chen

Fibroblast growth factor receptor 3 (FGFR3), highly conserved in both humans and murine, is one of key tyrosine kinase receptors for FGF. FGFR3 is expressed in different tissues, including cartilage, brain, kidney, and intestine at different development stages. Conventional knockout of Fgfr3 alleles leads to short life span, and overgrowth of bone. In clinic, human FGFR3 mutations are responsib...

Journal: :Blood 2005
Hong Chang A Keith Stewart Xiao Ying Qi Zhi Hua Li Qi Long Yi Suzanne Trudel

The t(4;14) translocation detected by fluorescence in situ hybridization (FISH) is an independent prognostic factor for an adverse outcome of multiple myeloma (MM). Because t(4;14) uniquely results in fibroblast growth factor receptor 3 (FGFR3) expression, decalcified, paraffin-embedded bone marrow biopsies were immunostained for FGFR3, and its expression was correlated with the t(4;14) status....

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید